BioDelivery Sciences International, Inc. (BDSI) CEO Herm Cukier on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/13/20
BioDelivery Sciences International (BDSI) Tops Q4 Earnings and Revenue EstimatesZacks Investment Research • 03/13/20
BioDelivery Sciences Announces Phase I Clinical Trial Results at the American Academy of Pain Medicine’s 36th Annual MeetingGlobeNewsWire • 02/27/20
BioDelivery Sciences Appoints Kevin Ostrander as Senior Vice President of Business DevelopmentGlobeNewsWire • 01/06/20
Are You Looking for a Top Momentum Pick? Why BioDelivery Sciences International (BDSI) is a Great ChoiceZacks Investment Research • 12/25/19
BioDelivery (BDSI) Up 6% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 12/12/19
What Makes BioDelivery Sciences International (BDSI) a Strong Momentum Stock: Buy Now?Zacks Investment Research • 12/06/19
BioDelivery Sciences to Present at the Piper Jaffray 31st Annual Healthcare ConferenceGlobeNewsWire • 11/27/19
BioDelivery Sciences Appoints Dr. Vanila Singh, Former Chief Medical Officer of Health and Human Services, to its Board of DirectorsGlobeNewsWire • 11/25/19
BioDelivery Sciences International's (BDSI) CEO Herm Cukier on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/13/19
BioDelivery Sciences International (BDSI) Beats Q3 Earnings and Revenue EstimatesZacks Investment Research • 11/12/19
BioDelivery Sciences International (BDSI) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 11/05/19